These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20032550)

  • 21. Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity.
    ter Hofstede HJ; Burger DM; Koopmans PP
    Neth J Med; 2003 Dec; 61(12):393-403. PubMed ID: 15025414
    [No Abstract]   [Full Text] [Related]  

  • 22. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
    Leclercq P; Blanc M
    Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipodystrophy syndrome. Therapeutic progress is still pending].
    Weber K; Heiken H; Stoll M; Schmidt RE; Behrens G
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():28-32. PubMed ID: 15011581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications of HIV disease and antiretroviral therapy.
    Currier JS; Havlir DV
    Top HIV Med; 2009; 17(2):57-67. PubMed ID: 19401608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
    Kong HH; Myers SA
    Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

  • 27. Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.
    Taiwo B; Hicks C; Eron J
    J Antimicrob Chemother; 2010 Jun; 65(6):1100-7. PubMed ID: 20348088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.
    Mallewa JE; Wilkins E; Vilar J; Mallewa M; Doran D; Back D; Pirmohamed M
    J Antimicrob Chemother; 2008 Oct; 62(4):648-60. PubMed ID: 18565973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications of HIV: lipodystrophy, anemia, renal, cardiovascular, and bone diseases.
    Balt CA; Nixon H
    Nurse Pract Forum; 2001 Dec; 12(4):199-213. PubMed ID: 11889688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
    McComsey G
    AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding and managing the adverse effects of antiretroviral therapy.
    Hawkins T
    Antiviral Res; 2010 Jan; 85(1):201-9. PubMed ID: 19857521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV and HIV treatment: effects on fats, glucose and lipids.
    Gkrania-Klotsas E; Klotsas AE
    Br Med Bull; 2007; 84():49-68. PubMed ID: 17981955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.
    Klibanov OM; Clark-Vetri R
    Pharmacotherapy; 2007 Jan; 27(1):122-36. PubMed ID: 17192166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HIV infection: emerging issues and new challenges].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2006 Dec; 97(12):771-80. PubMed ID: 17252736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Key reports from the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV 2007.
    Nestorowicz A; Cameron S
    Antivir Ther; 2007; 12(6):987-98. PubMed ID: 17926655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.
    Fisher SD; Kanda BS; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):383-94. PubMed ID: 22149317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International workshop on adverse drug reactions and co-morbiditles in HIV and the Tenth International Congress on Drug Therapy in HIV Infection in Glasgow.
    Taylor J
    Posit Aware; 2011; 23(1):20-1. PubMed ID: 21314022
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV medications: an update and review of metabolic complications.
    Hester EK
    Nutr Clin Pract; 2012 Feb; 27(1):51-64. PubMed ID: 22307491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral therapy-associated diseases are common in the long-term.
    Lanzafame M; Lattuada E; Zoppini G; Vento S
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
    [No Abstract]   [Full Text] [Related]  

  • 40. Report from the 11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV. Treatment for patients with central fat accumulation.
    Currier J
    J Watch AIDS Clin Care; 2010 Mar; 22(3):21-2. PubMed ID: 20480623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.